Angiogenin and MMP-2 as potential biomarkers in the differential diagnosis of gestational trophoblastic diseases
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028768
Abstract: Abstract Background: Gestational trophoblastic diseases (GTDs) are characterized by vascular abnormalities of the trophoblast, but their pathogenesis is unknown. Angiogenin (ANG) and matrix metalloproteinase (MMP)-2, which are molecules implicated in the angiogenic process, may play… read more here.
Keywords: potential biomarkers; gestational trophoblastic; biomarkers differential; trophoblastic diseases ... See more keywords
A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2022.805953
Abstract: Objective The aim of our study is to explore the most reliable panel of plasma biomarkers for differential diagnosis of parkinsonian syndromes (PDSs). We selected five kinds of neurodegenerative proteins in plasma: neurofilament light chain… read more here.
Keywords: biomarkers differential; plasma biomarkers; plasma; differential diagnosis ... See more keywords
Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58080994
Abstract: Background and Objectives: Pancreatic cystic lesions (PCLs) are frequently incidental findings. The prevalence of PCLs is increasing, mainly due to advancements in imaging techniques, but also because of the aging of the population. PCLs comprise… read more here.
Keywords: pcls; biomarkers differential; biochemical intracystic; pancreatic cystic ... See more keywords